# The Role of p66Shc in Cancer: Molecular Mechanisms and Therapeutic Implications

## TL;DR

This review explores how the p66Shc protein influences cancer development and potential treatments targeting it.

## Contribution

The paper provides a comprehensive overview of p66Shc's molecular mechanisms and therapeutic implications in cancer.

## Key findings

- p66Shc regulates oxidative stress and mitochondrial apoptosis in cancer cells.
- It plays a role in tumor progression, metastasis, and metabolic reprogramming.
- Therapeutic strategies like inhibitors and gene editing are being explored for targeting p66Shc.

## Abstract

p66Shc is a redox‐sensitive and pro‐apoptotic adaptor protein that regulates oxidative stress and mitochondrial apoptosis. It is the largest of three isoforms encoded by the proto‐oncogene ShcA (Src collagen homologue A). Members of the ShcA family are capable of recruiting various signalling molecules and are involved in several cellular pathways, including proliferation, growth and survival. Increasing evidence highlights the p66Shc role in various tumourigenic processes, such as cell expansion, progression, metastasis and metabolic reprogramming. This review summarises current knowledge on the role of p66Shc in cancer, explains the molecular mechanisms underlying the effects of this protein, and considers therapeutic prospects aimed at targeting it. Emerging therapeutic strategies, including small‐molecule inhibitors and gene‐editing approaches, are discussed alongside challenges in clinical translation.